title: The Sprint Fidelis implantable cardioverter-defibrillator (ICD) leads (Medtronic, Inc., Minneapolis, MN, USA) were removed from the market in October 2007 because of the rate of pace-sense conductor fractures.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Arias
authors.forename: Alberto
authors.initials: A
authors.lastname: Puchol
authors.forename: Eduardo
authors.initials: E
authors.lastname: Castellanos
authors.forename: Marta
authors.initials: M
authors.lastname: Pachón
mesh_terms: D001145:Arrhythmias, Cardiac / Q000628:therapy*; D017147:Defibrillators, Implantable; D004567:Electrodes, Implanted; D004868:Equipment Failure / Q000706:statistics & numerical data*; D006801:Humans; D008389:Marketing of Health Services / Q000191:economics / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D014481:United States